Wright Medical's back on track, eager to close BioMimetic buyout

Tue, 01/08/2013 - 7:45am
Mass Device

Orthopedic medical device maker Wright Medical's company-wide overhaul is on or ahead of schedule in most areas, and the company is looking forward to closing the $390 million buyout of BioMimetic Therapeutics.

Wright Medical Group logo

Orthopedic giant Wright Medical (NSDQ:WMGI) is back on track, CEO Robert Palmisano told an audience at the J.P. Morgan Healthcare conference in San Francisco yesterday.

Following a rough patch, which included a deferred prosecution agreement over allegations that the company engaged in illegal kickbacks for hip and knee devices, Wright is looking to turn things around.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.